METABOLIC ABNORMALITIES

Clinical trials for METABOLIC ABNORMALITIES explained in plain language.

Never miss a new study

Get alerted when new METABOLIC ABNORMALITIES trials appear

Sign up with your email to follow new studies for METABOLIC ABNORMALITIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1 Terminated 1

Promising drug for rare fat disorder trial halted early

Disease control Terminated

This study tested a drug called REGN4461 in people with familial partial lipodystrophy, a rare condition where fat is distributed abnormally, leading to serious metabolic issues like high triglycerides and diabetes. The trial aimed to see if the drug could improve blood fat and s…

Matched conditions: METABOLIC ABNORMALITIES

Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control

Last updated May 11, 2026 05:43 UTC

METABOLIC ABNORMALITIES

Get alerted when new METABOLIC ABNORMALITIES trials appear

Promising drug for rare fat disorder trial halted early